Sofia E. Magnusson
Uppsala, C 75318, Sweden
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
The Matrix-M™ adjuvant: A critical component of vaccines for the 21st century.
Journal: Human vaccines & immunotherapeutics
Published: April 28, 2023
Emergency department registered nurses overestimate their disaster competency: A cross-sectional study.
Journal: International emergency nursing
Published: January 22, 2021
Matrix-M™ adjuvant enhances immunogenicity of both protein- and modified vaccinia virus Ankara-based influenza vaccines in mice.
Journal: Immunologic research
Published: March 30, 2018
Protein and modified vaccinia virus Ankara-based influenza virus nucleoprotein vaccines are differentially immunogenic in BALB/c mice.
Journal: Clinical and experimental immunology
Published: June 13, 2017
Expression of perforin, granzyme A and Fas ligand mRNA in caecal tissues upon Eimeria tenella infection of naïve and immune chickens.
Journal: Parasite immunology
Published: February 10, 2016
Technologies for the development of West Nile virus vaccines.
Journal: Future microbiology
Published: November 19, 2014
Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.
Journal: PloS one
Published: August 06, 2014
Dysregulated Fc receptor function in active rheumatoid arthritis.
Journal: Immunology letters
Published: May 22, 2014
Matrix-M adjuvant: enhancing immune responses by 'setting the stage' for the antigen.
Journal: Expert review of vaccines
Published: August 30, 2013
Immune enhancing properties of the novel Matrix-M™ adjuvant leads to potentiated immune responses to an influenza vaccine in mice.
Journal: Vaccine
Published: September 03, 2012
Human cord blood derived immature basophils show dual characteristics, expressing both basophil and eosinophil associated proteins.
Journal: PloS one
Published: July 09, 2012
Last Updated: 09/26/2026